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F. Midulla1* and the Pertussis study groupAbstract
Background: Whether viral coinfections cause more severe disease than Bordetella pertussis (B. pertussis) alone remains
unclear. We compared clinical disease severity and sought clinical and demographic differences between infants with
B. pertussis infection alone and those with respiratory viral coinfections. We also analyzed how respiratory infections
were distributed during the 2 years study.
Methods: We enrolled 53 infants with pertussis younger than 180 days (median age 58 days, range 17–109 days, 64.
1% boys), hospitalized in the Pediatric Departments at “Sapienza” University Rome and Bambino Gesù Children’s
Hospital from August 2012 to November 2014. We tested in naso-pharyngeal washings B. pertussis and 14 respiratory
viruses with real-time reverse-transcriptase-polymerase chain reaction. Clinical data were obtained from hospital
records and demographic characteristics collected using a structured questionnaire.
Results: 28/53 infants had B. pertussis alone and 25 viral coinfection: 10 human rhinovirus (9 alone and 1 in coinfection
with parainfluenza virus), 3 human coronavirus, 2 respiratory syncytial virus. No differences were observed in clinical
disease severity between infants with B. pertussis infection alone and those with coinfections. Infants with B. pertussis
alone were younger than infants with coinfections, and less often breastfeed at admission.
Conclusions: In this descriptive study, no associations between clinical severity and pertussis with or without
co-infections were found.
Trial registration: Policlinico Umberto I: protocol 213/14, 3085/13.02.2014, retrospectively registered.
Bambino Gesù Children’s Hospital: protocol n. RF-2010-2317709.
Keywords: Pertussis, Respiratory virus, Severity, ChildBackground
Pertussis (whooping cough) is a highly contagious, respira-
tory disease caused by Bordetella pertussis (B. pertussis).
The clinical symptoms of pertussis change with age, previ-
ous exposure to B. pertussis and immunization status. In
newborns clinical manifestations may be severe. Most
infants have a typical paroxysmal cough which can last
more than two months [1].
Pertussis is a major cause of morbidity worldwide and
of mortality in infants in developing countries. Pertussis* Correspondence: midulla@uniroma1.it
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re-emergence despite high vaccination coverage [2].
Epidemic cycles reoccur every 2 to 5 years and 2015 has
witnessed the worst outbreak in the past 70 years [3].
Although ample evidence confirms coinfections between
B. pertussis and other pathogens, especially viruses, the
role of coinfections remains debated [4–6]. Most mixed
infections probably arise accidentally and whether they
cause more severe disease than B. pertussis alone remains
unclear [7–14]. Extending current knowledge on virus
coinfections would make it easier to care for infants with
pertussis.
We designed this study to compare clinical disease
severity in infants with B. pertussis infection alone andle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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in two Italian centers over two years. We also analyzed
how respiratory infections and pertussis cases were dis-
tributed during the two years study. As primary outcome
measures we assigned each infant a clinical severity
score and assessed length of hospitalization. As an
experimental approach to provide reliable data on lower
respiratory virus infections we used an extended respira-
tory virus panel that can detect 14 respiratory viral
targets with real-time reverse-transcriptase-polymerase
chain reaction (RT-PCR) assay.
Methods
Patients
In a longitudinal double-center study, we enrolled 53
consecutive infants with pertussis younger than 180 days
hospitalized from August 2012 to November 2014 at the
Pediatric Departments “Sapienza” University and Bambino
Gesù Children’s Hospital Rome. Eligible children had to
have a nasopharyngeal specimen that tested positive for B.
pertussis, be younger than 180 days, be unvaccinated
against pertussis and have at least one of the following
symptoms: cough lasting more than 5 days, paroxysmal
cough, apnea or cyanosis and post-cough vomit.
At admission all infants underwent a nasopharyngeal
washing obtained by instilling 3 ml of sterile saline into
each nostril and collected with a syringe. All samples
were delivered within two hours to the Department of
Infectious, Parasitic & Immune-mediated Diseases at the
Istituto Superiore di Sanità (Rome) for B. pertussis
detection and to the Molecular Medicine Department
(“Sapienza” University Rome Virology Laboratory) for
virus detection. We considered children with B. pertussis
infection, those with PCR positive results.
As primary outcome measures, we calculated at
admission a clinical score and days of hospitalization. The
clinical severity score ranged from 0 to 8, according toFig. 1 Monthly Distribution of the 53 Cases of Bordetella pertussis Infectionrespiratory rate (< 45/min = 0, 45–59/min = 1, > 60/
min = 2), arterial oxygen saturation in room air (> 95% = 0,
90–94% = 1, < 90% = 2), retractions (none = 0, present = 1,
present + nasal flare = 2) and food intake requirement
(normal = 0, reduced = 1, intravenous fluid = 2), as previ-
ously described [10]. Children’s parents were administered
a structured questionnaire seeking demographic data.
Demographic variables evaluated included gender, age at
admission (in days), gestational age, birth weight, type of
delivery, breastfeeding history, presence of siblings, number
of cohabitants, presence of smoking cohabitants and
cohabitants with concomitant respiratory symptoms. As
secondary outcome measures, we searched the clinical
records for data on the following clinical variables: heart
rate, respiratory rate, arterial oxygen saturation in room
air, retractions, oxygen-therapy, fluid therapy, episodes
of paroxysmal cough, cyanosis, apnea, post-cough
vomit, fever (body temperature > 37.5 °C), presence of
skin petechiae, conjunctival hemorrhage and complica-
tions (hypoxia, bradycardia, pneumonia, gastroenteritis,
thrombocytopenia, urinary tract infection, anemia, de-
hydration, feeding difficulties, transient hypertension).
Laboratory variables investigated were white blood-cell
count (WBC), lymphocyte count and C-reactive protein
(CRP). A chest X-ray (CXR) obtained at hospitalization
was evaluated blindly by a radiologist for consolidations.
Before infants were enrolled, all children’s parents
agreed and gave written informed consent to participate
in the study, which was approved by institutional review
boards at both hospitals (Policlinico Umberto I: protocol
213/14, 3085/13.02.2014; Bambino Gesù Children’s Hos-
pital: protocol n. RF-2010-2317709).
Bordetella pertussis detection by RT-PCR and culture
B. pertussis DNA was extracted with QIAamp DNA mini-
kit (QiaGEM, Hilden, Germania) and amplified with the
“Bordetella Real-Time PCR” kit (Diagenode Diagnostics,Through the 2-Year Study
Table 1 Days Hospitalization and Clinical Severity Scores in the Two Study Groups
Variables used to score clinical severity Pertussis
(N = 28 infants)
Pertussis + Virus
(N = 25 infants)
P Values
Hospitalization stay in days 7 (1–41) 7 (2–36) 0.532*
Severity score median (range) 1 (0–7) 1 (0–5) 0.279†
Heart rate in beats per minute median (range) 145 (100–175) 140 (120–175) 0.235†
Respiratory rate in breaths per minute median (range) 39 (27–70) 37 (27–60) 0.702†
Oxygen saturation median (range) 99% (85–100%) 98% (82–100%) 0.524†
Retractions 7/23 (30.4%) 4/22 (18.1%) 0.602*
Oxygen-therapy 8/23 (34.8%) 6/22 (27.3%) 0.413*
Fluid therapy 7/23 (30.4%) 2/22 (9.1%) 0.077*
*by χ-square test, † by Mann-Whitney test
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the SYBR Green Detection assay we used the LightCycler
2.0 system (Roche Diagnostic). Data were analyzed with
LightCycler software (version 4.0, Roche Diagnostic). Only
the positive samples for B. pertussis were cultured on
charcoal agar plates (Oxoid England) containing defibrin-
ated sheep blood at 10% and incubated at 35 °C up to
7 days and inspected daily, as previously described [13].Respiratory virus detection
Nasal washings were centrifuged to remove the mucus
present in the sample and an aliquot was used for nucleic
acid extraction using a total nucleic acid isolation kit
(Roche Diagnostics, Mannheim, Germany) and an RT-
PCR panel that sought 14 respiratory viruses: influenza
virus A and B (IV-A/B), human coronavirus (hCoV)
OC43, 229E, NL-63, HUK1, adenovirus (AV), parainflu-
enza virus 1–3 (PIV 1–3), human-metapneumovirus
(hMPV), human-bocavirus (hBoV), respiratory syncytial
virus (RSV) and human rhinovirus (hRV), as previously
described [10].Table 2 Demographic Variables in the Two Study Groups
Demographic variables Pertussis
(N = 28)
Boys 17 (60.7%)
Median age at hospitalization in days (range) 51.5 (17–102
Gestational age in weeks (range) 39 (35–41)
Birth weight in Kg (range) 3.345 (1.940
Cesarean section 10 (35.7%)
Breastfeeding at recovery 13 (46.4%)
Months breastfeeding 1.02 (0–2.14
Presence of siblings 16 (57.1%)
Number of cohabitants ≥4 19 (67.9%)
Passive smoke 10 (35.7%)
Co-habitants with respiratory symptoms 21 (75%)
*by χ-square test, † by Mann-Whitney testStatistical analysis
Statistical significance was analyzed with SPSS version
23.0 (SPSS Inc., Chicago, IL, USA). Data included per-
centages for discrete variables, median and range for
continuous variable. Differences among groups were
compared using non-parametric test for median com-
parison, Mann-Whitney test. The χ-square test was
applied to analyze categorical independent variables
qualitatively. P-values <0.05 were considered to indicate
statistical significance.
Results
Of 53 hospitalized infants (median age 58 days, range
17–109 days, 34 [64.1%] boys) with pertussis infection
enrolled, 28 (median age 51.5 days, range 17–102 days,
17 boys) had B. pertussis alone and 25 (median age
62 days, range 22–109 days, 17 boys) had viral coinfec-
tions. Among 25 patients with a coinfection, 9 were
coinfected with hRV, 3 with hCoV, 2 with RSV, 2 with
influenza virus (1 IVA and 1 IVB), 1 with PIV, 1 with
AV, 1 with hMPV, 1 with hBoV and 5 patients had
multivirus coinfections. Of these 53 patients, 3 had aPertussis + Virus
(N = 25)
P Values
17 (68%) 0.396*
) 62 (22–109) 0.044†
39 (37–41) 0.105†
–4.450) 3.250 (2.500–4.100) 0.618†
8 (32%) 0.503*
19 (76%) 0.048*
) 1.91 (0.27–3.58) 0.004†
19 (76%) 0.123*
22 (88%) 0.076*
11 (44%) 0.798*
22 (88%) 0.197*
Table 3 Clinical differences in the Two Study Groups
Clinical variables Pertussis
(N = 28)
Pertussis + Virus
(N = 25)
P Values*
Duration of symptoms before hospitalization (mean ± SD) 11.4 ± 7.8 13.1 ± 9.9 0.515
Paroxysmal cough 24 (85.7%) 19 (76%) 0.291
Cyanosis 16 (57.1%) 14 (56%) 0.576
Apnea 24 (85.9%) 20 (80%) 0.425
Post-cough vomit 15 (57.6%) 14 (56%) 0.540
Fever: T > 37.5 °C 3 (10.7%) 5 (20%) 0.288
Skin petechiae 1 (3.6%) 4 (16%) 0.142
Conjunctival hemorrhage 0 3 (12%) 0.098
Complicationsa 10 (35.7%) 6 (24%) 0.662
*by χ-square test
ahypoxia, bradycardia, pneumonia, gastroenteritis, thrombocytopenia, urinary tract infection, anemia, dehydration, feeding difficulties, transient hypertension
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(3 Pertussis alone and 1 coinfected) required pediatric
intensive care admission.
During the 2-year study B. pertussis infection alone was
detected mainly during the summer whereas coinfections
were equally distributed throughout the year (Fig. 1).
Clinical severity score and days hospitalization were
similar in children with B. pertussis infection alone and
those with B. pertussis and viral coinfection (Table 1).
The questionnaire indicated that infants with B.
pertussis alone were younger than infants with coin-
fections (p = 0.044 by Mann-Whitney test). Question-
naire answers also showed that infants with B.
pertussis alone were less often breastfeed at admission
than infants with coinfections (p = 0.048 by χ-square test)
and for a shorter time (p = 0.004 by Mann-Whitney test).
Finally, infants with coinfections more frequently had a
higher number of cohabitants though not significantly
(p = 0.076 by χ-square test).
The two groups had no significant differences for
other demographic, clinical, laboratory and radiological
data (Tables 2, 3 and 4).Discussion
In this descriptive study investigating the clinical data
for 53 infants younger than 180 days hospitalized withTable 4 Laboratory and Radiological Variables in the Two Study Gro
Laboratory and radiological variables Pertussis
(N = 28)
White blood cells (× 103 cells/μl) median (range) 15.38 (2.3
Lymphocytes (× 103 cells/μl) median (range) 8.31 (0.1–
WBC% Lymphocytes median (range) 61.9% (31
C-reactive protein (mg/dL) median (range) 0.05 (0–3
Consolidations on chest X-ray 4/16 (25%
*by χ-square test, †by Mann-Whitney testpertussis, no associations between clinical severity and
pertussis with or without co-infections were found.
As many as 25/53 (47%) of the infants hospitalized
with pertussis over the two years were coinfected with
other respiratory viruses. A distinctive point is that
because we analyzed a wide virus battery and did so in
infants hospitalized continuously in two centers over
two years we feel confident that our study provides reli-
able data on the distribution of respiratory infections.
Few studies found B. pertussis cases in infants with
respiratory pathogens. For example, Piedra et al., identi-
fied by RT-PCR only 4 B. pertussis cases in 2068 patients
with respiratory pathogens and all these infants were
younger than 6 months. In 3 of the 4 infants with B.
pertussis RT-PCR identified a second respiratory patho-
gen: 2 had an hRV and 1 child an hCoV coinfection [8].
In a similar study, Korppi et al., showed in a naso-
pharyngeal aspirate by RT-PCR B. pertussis infection in
7 on 9 of patients hospitalized for RSV infection [15].
Our lower percentage of coinfections reflects the ana-
lysis of a larger series of children with B. pertussis than
the other two studies.
As well as extending current epidemiological knowledge
on respiratory pathogens, we confirmed that pertussis in
Italy arises mainly during the summer months, whereas
respiratory virus coinfections are equally distributed over
the year [10]. Virological analysis showed that the mostups
Pertussis + Virus
(N = 25)
P Values
1–37.48) 17.04 (5.69–40.84) 0.110†
17.88) 6.89 (0.74–35.42) 0.272†
.3–81.6%) 61% (19.3–80.1%) 0.427†
.6) 0.05 (0.03–5.06) 0.461†
) 0/12 0.084*
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had RSV (8%). We presume that the distribution of coin-
fections reflects the observation that hRV epidemiology
maintains a steady epidemic curve throughout the
year and hRV can be detected also in asymptomatic
children. In fact in a Netherlands study conducted in
recent years Wildenbeest JG et al., found hRV in 25%
of asymptomatic children [16].
A new finding in this study is the lack of differences in
clinical disease severity (measured as clinical severity
score and days hospitalization) in infants with B. pertus-
sis infection alone and those with coinfections. Although
no other published studies have tested 14 respiratory
viruses in infants with pertussis, Nuolivirta et al., studied
142 infants aged less than 180 days hospitalized for
bronchiolitis who underwent a nasopharyngeal aspirate
to detect only 7 respiratory viruses and B. pertussis by
RT-PCR. B. Pertussis involvement was found in 12 of
142 (8.5%) infants hospitalized for bronchiolitis and, of
these, 8 were in coinfection with RSV. They found no
differences in clinical findings, days hospitalization and
breastfeeding at admission in patients with respiratory
viruses alone than in patients with respiratory viruses in
coinfections with B. pertussis [17]. Schnoeller et al.
showed that respiratory infection of neonatal mice with
an attenuated B. pertussis can protect against RSV-
induced disease in adult life [18, 19]. In a human model
Schiavoni et al. demonstrated that an attenuated B.
pertussis rescues the immune functions of RSV infected
human dendritic cells by promoting a protective Th1/
Th17 responses. Self-limiting respiratory infections with
attenuated bacteria or commensal microbes may have a
beneficial effect limiting potentially lethal diseases
caused by respiratory viruses in infants [20].
When we evaluated the secondary endpoints in our
study, infants with B. pertussis alone were younger, less
often breastfeed and breastfeed for a shorter time than
infants with coinfections. Similarly, in a previous study
from our group, comparing infants with B. pertussis and
those with bronchiolitis, we found that the percentage of
breastfed infants at hospitalization was lower in infants
with B. pertussis than in those with RSV bronchiolitis
[13]. This finding is difficult to explain. We always
strongly encourage breastfeeding in infants because it has
well-known immunological and nutritional advantages
[21]. In a recent large multicenter study, on pertussis-
associated pneumonia in children from low- and middle-
income countries, pertussis-positive cases were more likely
to have never been breastfed compared with controls [22].
Our finding might reflect mother-to-child transmission of
respiratory infections during breastfeeding.
Our study has limitations: small sample size and our
failure to compare B. pertussis infection with viral coin-
fections by single respiratory viruses.Conclusions
In conclusion, about one third of infants with B. pertussis
may have a respiratory viral coinfection. These undetected
coinfections seem to leave the clinical severity of pertussis
in infants unchanged.
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